Sclerostin levels during growth in children

Osteoporosis International

Volumn 23, Issue 3, 2012, Pages 1123-1130

  Kirmani, S ^a   Amin, S ^a   McCready, L K ^a   Atkinson, E J ^a   Melton III, L Joseph ^a   Muller R ^b   Khosla, S ^a  

^a MAYO CLINIC   (United States)

^b ETH ZURICH   (Switzerland)

Author keywords

Growth; Puberty; Sclerostin

Indexed keywords

SCLEROSTIN;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CHILD; CHILD DEVELOPMENT; CORTICAL BONE; FEMALE; HUMAN; MALE; NORMAL HUMAN; POROSITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; SEX DIFFERENCE; TRABECULAR BONE;

ADOLESCENT; AGE DETERMINATION BY SKELETON; AGING; BIOLOGICAL MARKERS; BONE DENSITY; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; BONE REMODELING; CHILD; FEMALE; GENETIC MARKERS; GROWTH AND DEVELOPMENT; HUMANS; MALE; POROSITY; PUBERTY; SEX CHARACTERISTICS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84857442198     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-011-1669-z     Document Type: Article

References (33)

1. R Baron G Rawadi 2007 Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton Endocrinology 148 2635 2643 17395698 10.1210/en.2007-0270 1:CAS:528:DC%2BD2sXmt1ajtrY%3D (Pubitemid 46984775)
2. V Krishnan HU Bryant OA MacDougald 2006 Regulation of bone mass by Wnt signaling J Clin Invest 116 1202 1209 16670761 10.1172/JCI28551 1:CAS:528:DC%2BD28XksVWgu7s%3D
3. RL van Bezooijen BAJ Roelen A Visser L van der Wee-Pals E de Wilt M Karperien H Hamersma SE Papapoulos P ten Dijke CWGM Lowik 2004 Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist J Exp Med 199 805 814 15024046 10.1084/jem.20031454 (Pubitemid 38375200)
4. M Semenov K Tamai X He 2005 SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor J Biol Chem 280 26770 26775 15908424 10.1074/jbc.M504308200 1:CAS:528:DC%2BD2MXmt1Ggs7k%3D (Pubitemid 41040710)
5. KES Poole RL van Bezooijen N Loveridge H Hamersma SE Papapoulos CW Lowik J Reeve 2005 Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation FASEB J 19 1842 1844 16123173 1:CAS:528: DC%2BD2MXht1emsbrP (Pubitemid 41598769)
6. RL van Bezooijen P ten Dijke SE Papapoulos CW Lowik 2005 SOST/sclerostin, an osteocyte-derived negative regulator of bone formation Cytokine Growth Factor Rev 16 319 327 15869900 10.1016/j.cytogfr.2005.02.005 (Pubitemid 40910321)
7. ME Brunkow JC Gardner J Van Ness, et al. 2001 Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein Am J Hum Genet 68 577 589 11179006 10.1086/318811 1:CAS:528:DC%2BD3MXit1altbk%3D (Pubitemid 32202753)
8. W Balemans M Ebeling N Patel, et al. 2001 Increase bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) Hum Mol Genet 10 537 543 11181578 10.1093/hmg/10.5.537 1:CAS:528: DC%2BD3MXhslSitbw%3D (Pubitemid 32184286)
9. K Staehling-Hampton S Proll BW Paeper, et al. 2002 A 52-kb deletion in the SOST-MEOX1 intergenic region on 17q12-q21 is associated with van Buchem disease in the Dutch population Am J Med Genet 110 144 152 12116252 10.1002/ajmg.10401 (Pubitemid 34569019)
10. W Balemans N Patel M Ebeling, et al. 2002 Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease J Med Genet 39 91 97 11836356 10.1136/jmg.39.2.91 1:CAS:528:DC%2BD38XitV2itbo%3D (Pubitemid 34146376)
11. X Li MS Ominsky Q-T Niu, et al. 2008 Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength J Bone Miner Res 23 860 869 18269310 10.1359/jbmr.080216 (Pubitemid 351768804)
12. X Li MS Ominsky KS Warmington, et al. 2009 Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis J Bone Miner Res 24 578 588 19049336 10.1359/jbmr.081206 1:CAS:528:DC%2BD1MXksF2lu7c%3D
13. D Padhi G Jang B Stouch L Fang E Posvar 2011 Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody J Bone Miner Res 26 19 26 20593411 10.1002/jbmr.173 1:CAS:528:DC%2BC3MXhtlCgsr8%3D
14. DA Glass II P Bialek JD Ahn, et al. 2005 Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation Dev Cell 8 751 764 15866165 10.1016/j.devcel.2005.02.017 1:CAS:528:DC%2BD2MXkslenur4%3D (Pubitemid 40585297)
15. UI Modder KA Hoey S Amin LK McCready SJ Achenbach BL Riggs LJI Melton S Khosla 2011 Relation of age, gender, and bone mass to circulating sclerostin levels in women and men J Bone Miner Res 26 373 379 20721932 10.1002/jbmr.217 1:CAS:528:DC%2BC3MXjt1Wqsrc%3D
16. DA Bailey AD Martin HA McKay S Whiting R Mirwald 2000 Calcium accretion in girls and boys during puberty: a longitudinal analysis J Bone Miner Res 15 2245 2250 11092406 10.1359/jbmr.2000.15.11.2245 1:CAS:528:DC%2BD3cXnvVKltLk%3D
17. S Kirmani D Christen GH van Lenthe, et al. 2009 Bone structure at the distal radius during adolescent growth J Bone Miner Res 24 1033 1042 19113916 10.1359/jbmr.081255
18. S Khosla LJ Melton III MB Dekutoski SJ Achenbach AL Oberg BL Riggs 2003 Incidence of childhood distal forearm fractures over 30 years: a population-based study JAMA 290 1479 1485 13129988 10.1001/jama.290.11.1479 1:CAS:528:DC%2BD3sXntlCmsb8%3D (Pubitemid 37430403)
19. LA Landin 1983 Fracture patterns in children. Analysis of 8,682 fractures with special reference to incidence, etiology and secular changes in a Swedish urban population 1950-1979 Acta Orthop Scand Suppl 202 1 109 6574687 1:STN:280:DyaL3s3islWisQ%3D%3D
20. M Kramhoft S Bodtker 1988 Epidemiology of distal forearm fractures in Danish children Acta Orthop Scand 59 557 559 3188862 10.3109/17453678809148784 1:STN:280:DyaL1M%2Fks1CrtA%3D%3D (Pubitemid 18264556)
21. DA Bailey JH Wedge RG McCulloch AD Martin SC Bernhardson 1989 Epidemiology of fractures of the distal end of the radius in children as associated with growth J Bone Joint Surg 71-A 1225 1231 (Pubitemid 19262372)
22. Tanner JM, Healy MJR, Goldstein H et al (2001) Assessment of skeletal maturity and prediction of adult height: TW3 method. Saunders, Philadelphia
23. A Laib T Hildebrand HJ Hauselmann P Ruegsegger 1997 Ridge number density: a new parameter for in vivo bone structure analysis Bone 21 541 546 9430245 10.1016/S8756-3282(97)00205-6 1:STN:280:DyaK1c%2FptVWisg%3D%3D (Pubitemid 28029698)
24. A Laib HJ Hauselmann P Ruegsegger 1998 In vivo high resolution 3D-QCT of the human forearm Technol Health Care 6 329 337 10100936 1:STN:280: DyaK1M7pvFSgtw%3D%3D (Pubitemid 29090456)
25. Parfitt AM (1983) Stereologic basis of bone histomorphometry: Theory of quantitative microscopy and reconstruction of the third dimension. CRC Press, Boca Raton
26. A Laib P Ruegsegger 1999 Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography Bone 24 35 39 9916782 10.1016/S8756-3282(98)00159-8 1:STN:280:DyaK1M7htlyhsg%3D%3D (Pubitemid 28546704)
27. JA MacNeil SK Boyd 2007 Accuracy of high-resolution peripheral quantitative computed tomography for measurement of bone quality Med Eng Phys 29 1096 1105 17229586 10.1016/j.medengphy.2006.11.002 (Pubitemid 350052626)
28. E Terpos D Christoulas E Katodritou, et al. 2009 High serum sclerostin correlates with advanced stage, increased bone resorption, reducted osteoblast function, and poor survival in newly-diagnosed patients with multiple myeloma Blood 114 425 10.1182/blood-2008-03-145821 Abstract
29. UIL Modder JA Clowes K Hoey JM Peterson L McCready MJ Oursler BL Riggs S Khosla 2011 Regulation of circulating sclerostin levels by sex steroids in women and men J Bone Miner Res 26 27 34 20499362 10.1002/jbmr.128 1:CAS:528:DC%2BC3MXhtlCgsrw%3D
30. A Gaudio P Pennisi C Bratengeier V Torrisi B Lindner RA Mangiafico I Pulvirenti G Hawa G Tringali CE Fiore 2010 Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immoilization-induced bone loss J Clin Endocrinol Metab 95 2248 2253 20305005 10.1210/jc.2010-0067 1:CAS:528:DC%2BC3cXmtFegu7Y%3D
31. S Khosla S Amin RJ Singh EJ Atkinson LJ Melton BL Riggs 2008 Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density Osteoporos Int 19 1465 1471 18338096 10.1007/s00198-008-0591-5 1:CAS:528:DC%2BD1cXhtVOiu7fJ
32. MT Drake B Srinivasan UI Modder JM Peterson LK McCready BL Riggs D Dwyer M Stolina P Kostenuik S Khosla 2010 Effects of parathyroid hormone treatment on ciculating sclerostin levels in postmenopausal women J Clin Endocrinol Metab 95 5056 5062 20631014 10.1210/jc.2010-0720 1:CAS:528:DC%2BC3cXhsV2nsbnP
33. AJ Burghardt HR Buie A Laib S Majumdar SK Boyd 2010 Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT Bone 47 519 528 20561906 10.1016/j.bone.2010.05.034